Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center ; day:12 ; month:08 ; year:2023
South Asian journal of cancer ; (12.08.2023)
- Contributor
-
Indhuja, Muthiah Vaikundaraja
Kesana, Sivasree
Mehra, Nikita
Karunakaran, Parathan
Rajan, Arun Kumar
Radhakrishnan, Venkatraman
Jayachandran, Perumal Kalaiyarasi
- DOI
-
10.1055/s-0042-1758353
- URN
-
urn:nbn:de:101:1-2023092811203954807461
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Indhuja, Muthiah Vaikundaraja
- Kesana, Sivasree
- Mehra, Nikita
- Karunakaran, Parathan
- Rajan, Arun Kumar
- Radhakrishnan, Venkatraman
- Jayachandran, Perumal Kalaiyarasi
Other Objects (12)
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)